In Depth 26 Jan 2024
Long COVID: are we on the verge of a breakthrough?
Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities.
- Latest Posts
Podcast 26 Jan 2024
Transforming the vaginal microbiome to combat infertility
Freya Biosciences is a clinical-stage biotech company with headquarters in Copenhagen, Denmark, and Boston, Massachusetts. It is dedicated to reimagining women’s health and redefining fertility for those previously deprived of options. With a focus on microbial immunotherapies, Freya addresses immune drivers underlying a range of reproductive health conditions. The company recently received $38 million Series […]
In Depth 25 Jan 2024
The trends that will shape the biotech industry in 2024
What does 2024 hold for the biotech industry? Delve into the experts’ insight on the biotech trends that will shape 2024.
Best in Biotech 25 Jan 2024
Eight mental health biotech companies trying to make a difference to people’s lives
Take a closer look at eight mental health companies developing therapies that could make a different to people with mental illnesses.
In Depth 24 Jan 2024
A new chapter in cell therapy: engineered B cells reach the clinic for the first time
Cell therapy has drastically improved the scope of treatment for a number of diseases in the last few years. Now, engineered B cells are the latest approach in the field of cell therapy, having recently made it into clinical trials. But what exactly are B cells and how can they be engineered to treat diseases? […]
Best in Biotech 22 Jan 2024
Eight newly approved drugs that could become blockbusters in 2024
The much-awaited Drugs to Watch list by Clarivate is out. Let’s do a deep dive into the therapies that made the cut in 2024.
ADVERTISEMENT
ADVERTISEMENT
In Depth 19 Jan 2024
Re-coding the brain: Is CRISPR capable of curing neurodegenerative diseases?
Check out our latest article as we explore some of the latest research around using CRISPR technology to treat neurodegenerative diseases.
Podcast 19 Jan 2024
Epigenetic editing – the power of CRISPR without cutting DNA
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]
In Depth 18 Jan 2024
GLP-1 agonists: what’s the hype about?
GLP-1 agonists have been on the radar for a while to treat diabetes and obesity. And of late, there has been renewed interest in these drugs.
News and Trends 18 Jan 2024
2024 J.P. Morgan Healthcare Conference: key takeaways from the largest biotech gathering of the year
Here are some of the key takeaways from the JPM Healthcare Conference that lay the groundwork for what we can expect in 2024.
In Depth 17 Jan 2024
Bladder cancer treatment: where are we standing?
Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment.
Best in Biotech 16 Jan 2024
Five biotech companies taking Florida by storm
Check out five of the top Florida companies taking the state’s biotech industry by storm with their innovative technologies.
ADVERTISEMENT
